MP5 Clozapine Prescribing and Monitoring Guideline


Category
Medicine management
Code
MP5
Issue No
6.2

Target Audience

All CWP staff

Purpose

The purpose of this guidance is to set out the standards for clinicians, pharmacy service providers, nursing staff and other health care professionals involved in the prescribing, administration and monitoring of clozapine. It covers initiation of clozapine (inpatient and community setting) and continuation of monitoring following initiation.

Origin

Lead executive
Medical Director

Author and contact number
Deputy Chief Pharmacist - 01244 397494
Senior Clinical Pharmacist - 01244 397355
Medicines Safety Pharmacist - 01244 397494


Policy dates & history

Implementation Date

22 July 2017

Approval Meeting

Medicines Management Group


Appendices

Download

MP5 Issue 6.2 Clozapine Prescribing and Monitoring Guideline.pdf (1)

0.95MB
Download Now
Text size A- A+
Contrast options